PharmaCorp Rx Inc.

C$0.40As of Sun 8 Nov 2026, 12:00 UTC
TSXV:PCRXHealthcare
Country Canada
PE (Fwd) •••
TSR 4Y CAGR 33.66%
Div yield —
ROE (2.51%)
Pharmaceutical Retailers
Beta (5Y) (3.95)
PE TTM —
TSR TTM (17.71%)
Mkt cap C$77.81M
ROIC (3.89%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.444
12.33%
(36.61%)
Hold 1|3|12|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
0.01
23.37%
13.47%
18.63%
19.17%
Revenue$M
5.781
5.893
5.923
6.005
3.92%
2.16%
5.37%
1.14%
Peers (US$55.07M)
Cap (US$)
PE
235.3M
—
41.19M
37.78x
62.64M
13.07x
Capital
TTM
5Y
10Y
Leveragex
0.392
—
—
EBIT/Intx
7.879
0.263
0.271
Own earn%
60.53
12.99
(7.34)
Sh yield%
40.63
25.73
27.21
Owners
Insiders/Inst%
10.19
47.10
Short interest%
4.51
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
9–20
$1 testx
—
Incr. ROIC%
0